NKP-1339

· Niiki Pharma Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NKP-1339, covering 2017-05-19 to 2017-05-19. Get the full timeline:

Most recent: Clinical Trial Update: Dose Escalation Study of NKP-1339 to Treat Advanced Solid Tumors [Phase 1]